.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Express Scripts
Argus Health
Moodys
McKinsey
Accenture
UBS
Dow
Julphar
US Army

Generated: December 17, 2017

DrugPatentWatch Database Preview

Dihydroergotamine mesylate - Generic Drug Details

« Back to Dashboard

What are the generic sources for dihydroergotamine mesylate and what is the scope of dihydroergotamine mesylate patent protection?

Dihydroergotamine mesylate
is the generic ingredient in four branded drugs marketed by Valeant, Hikma Pharms, Paddock Llc, West-ward Pharms Int, and Novartis, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for dihydroergotamine mesylate. Five suppliers are listed for this compound.

Pharmacology for dihydroergotamine mesylate

Ingredient-typeErgotamines
Drug ClassErgotamine Derivative

Medical Subject Heading (MeSH) Categories for dihydroergotamine mesylate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
NovartisEMBOLEXdihydroergotamine mesylate; heparin sodium; lidocaine hydrochlorideINJECTABLE;INJECTION018885-001Nov 30, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
NovartisEMBOLEXdihydroergotamine mesylate; heparin sodium; lidocaine hydrochlorideINJECTABLE;INJECTION018885-002Nov 30, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
ValeantMIGRANALdihydroergotamine mesylateSPRAY, METERED;NASAL020148-001Dec 8, 1997RXYesYes► Subscribe► Subscribe► Subscribe
Hikma PharmsDIHYDROERGOTAMINE MESYLATEdihydroergotamine mesylateINJECTABLE;INJECTION206621-001Sep 15, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms IntDIHYDROERGOTAMINE MESYLATEdihydroergotamine mesylateINJECTABLE;INJECTION040453-001Jun 9, 2003APRXNoNo► Subscribe► Subscribe► Subscribe
ValeantD.H.E. 45dihydroergotamine mesylateINJECTABLE;INJECTION005929-001Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe
Paddock LlcDIHYDROERGOTAMINE MESYLATEdihydroergotamine mesylateINJECTABLE;INJECTION040475-001Apr 28, 2003APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: dihydroergotamine mesylate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
ValeantMIGRANALdihydroergotamine mesylateSPRAY, METERED;NASAL020148-001Dec 8, 1997► Subscribe► Subscribe
ValeantMIGRANALdihydroergotamine mesylateSPRAY, METERED;NASAL020148-001Dec 8, 1997► Subscribe► Subscribe
ValeantMIGRANALdihydroergotamine mesylateSPRAY, METERED;NASAL020148-001Dec 8, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Teva
Queensland Health
Federal Trade Commission
McKesson
Dow
Johnson and Johnson
Deloitte
Novartis
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot